Galectin-1 is up-regulated by RASSF1A gene in human gastric carcinoma cell line SGC7901
Deng Zheng-Hao
Department of Pathology, XiangYa School of Medicine, Central South University, Changsha, Hunan Province, China
Search for more papers by this authorWen Ji-Fang
Department of Pathology, XiangYa School of Medicine, Central South University, Changsha, Hunan Province, China
Search for more papers by this authorXiao De-Sheng
Department of Pathology, XiangYa School of Medicine, Central South University, Changsha, Hunan Province, China
Search for more papers by this authorCorresponding Author
Zhou Jian-Hua
Department of Pathology, XiangYa School of Medicine, Central South University, Changsha, Hunan Province, China
Zhou Jian-Hua, Department of Pathology, XiangYa School of Medicine, Central South University, Chang Sha, Hunan Province, China, 410078. e-mail: [email protected]Search for more papers by this authorDeng Zheng-Hao
Department of Pathology, XiangYa School of Medicine, Central South University, Changsha, Hunan Province, China
Search for more papers by this authorWen Ji-Fang
Department of Pathology, XiangYa School of Medicine, Central South University, Changsha, Hunan Province, China
Search for more papers by this authorXiao De-Sheng
Department of Pathology, XiangYa School of Medicine, Central South University, Changsha, Hunan Province, China
Search for more papers by this authorCorresponding Author
Zhou Jian-Hua
Department of Pathology, XiangYa School of Medicine, Central South University, Changsha, Hunan Province, China
Zhou Jian-Hua, Department of Pathology, XiangYa School of Medicine, Central South University, Chang Sha, Hunan Province, China, 410078. e-mail: [email protected]Search for more papers by this authorAbstract
We have previously shown that overexpression of RASSF1A inhibits the growth of human gastric cancer SGC7901 cells, but the underlying mechanism remains unknown. In this study, the differential protein expression by RASSF1A gene in human gastric cancer cell line SGC7901 was determined by 2-D gel electrophoresis combined with matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) and bioinformatics. Differential expression analysis of the protein profiles by RASSF1A gene identified a total of 35 protein spots, of which 10 were up-regulated and 25 were down-regulated. Eight proteins were identified by MALDI-TOF MS: Galectin-1, TRP-14, ACBP, PSMB5, PSMB4, TIM, vimentin, CD79α. RASSF1A up-regulated the mRNA expression of Galectin-1, TRP-14, ABCP in SGC7901. RASSF1A also led to an increased expression of Galectin-1 protein in SGC7901 confirmed by western blotting and immunocytochemistry analysis. RASSF1A inhibited the activity of NF-κB in SGC7901 cells. These data indicated that Galectin-1 may be playing a role in RASSF1A signaling in SGC7901.
References
- 1Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006; 12: 354–62.
- 2Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 2000; 25: 315–9. 4
- 3Agathanggelou A, Cooper WN, Latif F. Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res 2005; 65: 3497–508.
- 4Ye M, Xia B, Guo Q, Zhou F, Zhang X. Association of diminished expression of RASSF1A with promoter methylation in primary gastric cancer from patients of central China. BMC Cancer 2007; 7: 120.
- 5Wang YC, Yu ZH, Liu C, Xu LZ, Yu W, Lu J, et al. Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients. World J Gastroenterol 2008; 14: 3074–80.
- 6Deng ZH, Wen JF, Li JH, Xiao DS, Zhou JH. Activator protein-1 involved in growth inhibition by RASSF1A gene in the human gastric carcinoma cell line SGC7901. World J Gastroenterol 2008; 14: 1437–43.
- 7Richter AM, Pfeifer GP, Dammann RH. The RASSF proteins in cancer; from epigenetic silencing to functional characterization. Biochim Biophys Acta 2009; 1796: 114–28.
- 8Ahmed-Choudhury J, Agathanggelou A, Fenton SL, Ricketts C, Clark GJ, Maher ER, et al. Transcriptional regulation of cyclin A2 by RASSF1A through the enhanced binding of p120E4F to the cyclin A2 promoter. Cancer Res 2005; 65: 2690–7.
- 9Whang YM, Kim YH, Kim JS, Yoo YD. RASSF1A suppresses the c-Jun-NH2-kinase pathway and inhibits cell cycle progression. Cancer Res 2005; 65: 3682–90.
- 10Thaler S, Hähnel PS, Schad A, Dammann R, Schuler M. RASSF1A mediates p21Cip1/Waf1-dependent cell cycle arrest and senescence through modulation of the Raf-MEK-ERK pathway and inhibition of Akt. Cancer Res 2009; 69: 1748–57.
- 11Deng ZH, Cao HQ, Hu YB, Wen JF, Zhou JH. TRX is up-regulated by fibroblast growth factor-2 in lung carcinoma. APMIS 2011; 119: 57–65.
- 12Bo LI, De-Yun F, Rui-Xue C, Shu-Yan S, Qiong-Qiong H, Zhong-Liang H, et al. The mechanisms for HCV NS3 protein upregulating cell proliferation in human hepatocytes. Prog Biochem Biophys 2005; 32: 991–7.
- 13Feng X-P, Yi H, Li M-Y, Li X-H, Yi B, Zhang P-F, et al. Identification of biomarkers for predicting nasopharyngeal carcinoma response to radiotherapy by proteomics. Cancer Res 2010; 70: 3450–62.
- 14Burbee DG, Forgacs E, Zochbauer-Muller S, Shivakumar L, Fong K, Gao B, et al. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 2001; 93: 691–9.
- 15Verma SK, Ganesan TS, Kishore U, Parker PJ. The tumor suppressor RASSF1A is a novel effector of small G protein Rap1A. Protein Cell 2011; 2: 237–49.
- 16Guo C, Zhang X, Pfeifer GP. The tumor suppressor RASSF1A prevents dephosphorylation of the mammalian STE20-like kinases MST1 and MST2. J Biol Chem 2011; 286: 6253–61.
- 17Jeong W, Yoon HW, Lee SR, Rhee SG. Identification and characterization of TRP14, a thioredoxin-related protein of 14 kDa. J Biol Chem 2004; 279: 3142–50.
- 18Jeong W, Chang TS, Boja ES, Fales HM, Rhee SG. Roles of TRP14, a thioredoxin-related protein in tumor necrosis factor-asignaling pathways. J Biol Chem 2004; 279: 3151–9.
- 19Whang YM, Kim YH, Kim JS, Yoo YD. RASSF1A suppresses the c-Jun-NH2-kinase pathway and inhibits cell cycle progression. Cancer Res 2005; 65: 3682–90.
- 20Schroeder F, Petrescu AD, Huang H, Atshaves BP, McIntosh AL, Martin GG, et al. Role of fatty acid binding proteins and long chain fatty acids in modulating nuclear receptors and gene transcription. Lipids 2008; 43: 1–17.
- 21Lee BC, Cha K, Avraham S, Avraham HK. Microarray analysis of differentially expressed genes associated with human ovarian cancer. Int J Oncol 2004; 24: 847–51.
- 22Gossett RE, Schroeder F, Gunn JM, Kier AB. Expression of fatty acyl-CoA binding proteins in colon cells: response to butyrate and transformation. Lipids 1997; 32: 577–85.
- 23Camby I, Mercier ML, Lefranc F, Kiss R. Galectin-1: a small protein with major functions. Glycobiology 2006; 16: 137R–57R.
- 24Thijssen VL, Barkan B, Shoji H, Aries IM, Mathieu V, Deltour L, et al. Tumor cells secrete galectin-1 to enhance endothelial cell activity. Cancer Res 2010; 70: 6216–24.
- 25Paz A, Haklai R, Elad-Sfadia G, Ballan E, Kloog Y. Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation. Oncogene 2001; 20: 7486–93.
- 26Demydenko D, Berest I. Expression of galection-1 in malignant tumors. Exp Oncol 2009; 31: 74–9.
- 27Rabinovich GA. Galectin-1 as a potential cancer target. Br J Cancer 2005; 92: 1188–92.
- 28Bektas S, Bahadir B, Ucan BH, Ozdamar SO. CD24 and galectin-1 expressions in gastric adenocarcinoma and clinicopathologic significance. Pathol Oncol Res. 2010; 16: 569–77.
- 29Satelli A, Subrahmanyeswara Rao U. Galectin-1 is silenced by promoter hypermethylation and its re-expression induces apoptosis in human colorectal cancer cells. Cancer Lett 2011; 301: 38–46.
- 30Sanchez-Ruderisch H, Detjen KM, Welzel M, André S, Fischer C, Gabius H-J, et al. Galectin-1 sensitizes carcinoma cells to anoikis via the fibronectin receptora5b1-integrin. Cell Death Differ 2011; 18: 806–16.
- 31Fischer C, Sanchez-Ruderisch H, Welzel M, Wiedenmann B, Sakai T, André S, et al. Galectin-1 Interacts with theα5β1Fibronectin Receptor to Restrict Carcinoma Cell Growth via Induction of p21 and p27. J Biol Chem 2005; 280: 37266–77.
